Human observational studies link the pandemic with higher mortality and lower physical activity across independent labs, and with shorter male life expectancy and higher brain-age and epigenetic-age measures. Some studies show no clear mortality link, while a study links it with higher activity. Some papers declare company ties.
403 findings in 235 papers from 2020 to 2026, 42 of them since April 2026
Independent labs found the same change in people. 181 independent labs in 41 countries.
“LSNS-6 scores at follow-up showed a negative trend throughout the observation period (Fig., Panels A and B), and later pandemic phases were associated with an increasing probability of observing lower levels of social involvement and higher risk for social isolation (Fig., Panels C and D). < Fig. >.”
Humans: replicated by independent labs. Cells, worms or flies and mice: nothing yet.
C, W, M, H: cells, worms or flies, mice, humans. Dark: independent labs found the same change there. Light: one lab or one study. Outline: nothing yet.
Labs are independent when their papers share no last author and no institution.
Against: findings that point the other way from most findings on the same outcome.
Company ties: findings with an author at a company, or from a paper whose competing-interests statement declares ties to one.
181 independent labs in 41 countries
20 findings against
Funders: National Institutes of Health and others
24 of 396 findings with company ties
Human trial2
Humans303
In silico13
What did studies of COVID-19 pandemic find?
189
Studies of COVID-19 pandemic measured 189 outcomes; the most studied are mortality (22 studies), cognitive function (9) and life expectancy (8).
Mortality
↑upin humans16↔no changein humans5↑upin silico1+10% to +26%
22 studies
COVID-19 pandemic is linked with higher mortality in humans (approximately 12 and 5% points higher in men).
“Excess mortality rates were higher among men than women by approximately 12 and 5% points in 2020 and 2021, with the majority occurring in residents aged 45 and older.”
COVID-19 pandemic is linked with higher mortality in humans (pandemic 14% vs. 15.4%, before the pandemic 3.1%).
“The mortality rate during the pandemic did not differ between patients tested positive or patients tested negative but was significantly higher for both groups in comparison to the period before the pandemic”
Humanspatients surgically treated for proximal femoral fracture during COVID-19 pandemic vs prepandemicn = 2,186
COVID-19 pandemic is linked with worse cognitive function in humans (difference-in-differences model from Wave2 to Wave3) (coefficient: -0.808 [95% CI: -1.079, -0.537]).
“The difference‐in‐differences model showed more significant declines in MMSE and executive function from Wave2 to Wave3(coefficient[95%CI]: ‐0.808[‐1.079, ‐0.537]).”
Humansdifference-in-differences model from Wave2 to Wave3
COVID-19 pandemic is linked with worse cognitive function in older patients with cognitive impairment (1.87 points/year vs 0.46 points/year).
“The time series analysis showed an accelerated cognitive trajectory after the COVID-19 outbreak, and the average decline in the Mini-Mental State Examination scores was 0.46 points (95% confidence interval 0.034-0.91) per year before the COVID-19 pandemic, and a steeper decline of 1.87 points (95% confidence interval 1.34-2.67) per year after the outbreak.”
Humansin older patients with cognitive impairment4-yearn = 160
COVID-19 pandemic is linked with lower life expectancy in 2020 (loss of 0.40 years).
“During the first pandemic year 2020, the most affected group was males with an intermediate level of education, showing life expectancy loss of 0.40 years.”
COVID-19 pandemic is linked with worse physical function in humans during COVID-19 pandemic (p = 0.003).
“the scores deteriorated significantly for activities of daily living (p < 0.001), physical function (p = 0.003), oral function (p < 0.001), outdoor activity (p < 0.001), and depression (p < 0.001).”
COVID-19 pandemic is linked with higher loneliness in humans (COVID-19 pandemic) (50.5% vs. 30.75%).
“the adjusted prevalence of loneliness increased to 50.5% (95% CI: 48.0%-53.1%) during the pandemic compared to 30.75% (95% CI: 28.72%-32.85%) pre-pandemic.”
COVID-19 pandemic is linked with lower physical activity in humans (from 36.0% to 30.0% in 2020 and 29.7% in 2021).
“During the pandemic, the prevalence of sufficient physical activity decreased significantly, from 36.0% (95% CI, 35.9% to 36.1%) in 2017 to 2019 to 30.0%”
COVID-19 pandemic is linked with lower physical activity in humans during the pandemic (-33.3% (first wave), -28.3% (second wave), -40.0% (third wave)).
“The total PA time during the first, second, and third waves of the pandemic decreased from the pre-pandemic PA time by 33.3%, 28.3%, and 40.0%, respectively.”
COVID-19 pandemic decreases social participation in humans (OR 1.23 [95% CI: 1.05–1.44] for risk for social isolation).
“LSNS-6 scores at follow-up showed a negative trend throughout the observation period (Fig., Panels A and B), and later pandemic phases were associated with an increasing probability of observing lower levels of social involvement and higher risk for social isolation (Fig., Panels C and D). < Fig. >.”
COVID-19 pandemic decreases social participation in humans (OR 0.84 [95% CI: 0.75-0.95]).
“Later phases of the Covid-19 pandemic showed a negative impact on the level of social participation at follow-up with an OR of 0.84 [95% CI: 0.75-0.95].”
COVID-19 pandemic is linked with lower physical activity in humans (veterans with implanted cardiac devices) (-0.37 hr/day (95% CI: 0.29 to 0.45; p < 0.0001)).
“representing a mean decrease of 0.37 hr/day (95% CI: 0.29 to 0.45; p < 0.0001)”
Humansveterans with implanted cardiac devices2018 through 2022n = 360
COVID-19 pandemic is linked with higher physical activity in humans.
“Physical activity increased from the 7-year visit to the pandemic study point (p<0.001 in the control group; p<0.001 in the intervention group), which was of opposite to the decline in physical activity detected during the follow-up prior the pandemic.”
COVID-19 pandemic is associated with mortality in humans (aOR > 1.00; p < 0.05).
“Mortality rates increased significantly during the pandemic for CLD, stroke, chronic liver disease, autoimmune disease, CKD, and DPD”
HumansPatients with chronic lung disease, stroke, chronic liver disease, autoimmune disease, chronic kidney disease, or dementia/Parkinson's disease in South Korea; compared with the pre-pandemic period2020–2022
COVID-19 pandemic is linked with a higher risk of mortality in humans during the pandemic.
“Mortality rates, particularly among females, as well as individuals, aged 65+, increased from 2019 to 2021 (during the pandemic) reversing the progressive declining trend from 2016 to 2019.”
Journal of the American Medical Directors Association·
COVID-19 pandemic is linked with a higher risk of mortality in humans (comparing pandemic and pre-pandemic periods) (HR 1.25 (95% CI 1.25-1.26)).
“Overall, the excess mortality rate was 10.0 deaths/1000 person-years (PY), with a total of 103 164 excess deaths and pandemic HR of 1.25 (95% CI 1.25-1.26).”
Humanscomparing pandemic and pre-pandemic periodsn = 5,905,747
COVID-19 pandemic is linked with a higher risk of mortality in humans (10.0 deaths/1000 person-years, 103,164 excess deaths, HR 1.25 (95% CI 1.25-1.26)).
“Overall, the excess mortality rate was 10.0 deaths/1000 person-years (PY), with a total of 103,164 excess deaths and pandemic HR of 1.25 (95% CI 1.25-1.26).”
COVID-19 pandemic is linked with a higher risk of mortality in humans (geriatric hip fracture).
“Thirty-day mortality was significantly different between groups, with no deaths of 24 patients in the pre-COVID-19 cohort versus six deaths of 23 patients (26.1%) in the COVID-19 cohort”
COVID-19 pandemic is associated with mortality in humans (39.6 vs 37.2 per 1000 py, aIRR 1.09 (95% CI 0.84-1.41)).
“All-cause mortality in 2020 was 39.6 per 1000 py, as compared to 37.2 per 1000 py pre- pandemic (Adjusted Incidence Rate Ratio = 1.09, 95%: confidence interval: 0.84-1.41).”
Humansfirst year of the COVID-19 pandemic (Mar-Dec 2020) compared to pre-pandemic (Jan 2015-Feb 2020)n = 3,510
COVID-19 pandemic is associated with depressive symptoms in humans during the pandemic compared with the prepandemic period (Twice the odds compared with the prepandemic period).
“adults had twice the odds of depressive symptoms during the pandemic compared with the prepandemic period”
Humansduring the pandemic compared with the prepandemic period
COVID-19 pandemic is associated with loneliness in humans (highest tertile vs lowest tertile of COVID-19 exposure index) (OR: 2.97; 95% CI: 2.08 to 4.26).
“loneliness (OR: 2.97; 95% CI: 2.08 to 4.26) than those in the lowest tertile.”
Humanshighest tertile vs lowest tertile of COVID-19 exposure indexn = 1,089
COVID-19 pandemic is associated with loneliness in humans (33.1% pre-pandemic to 20.6% round 3).
“The overall prevalence of loneliness in the pre-pandemic period was 33.1% (95%CI: 29.4-36.8), higher than the pandemic period (round 1: 23.6%, 95%CI: 20.6-26.9; round 2: 20.5%, 95%CI: 17.8-23.5; round 3: 20.6%, 95%CI: 17.1-24.6).”
COVID-19 pandemic is associated with loneliness in humans during COVID-19 pandemic (28.6% (95% CI: 22.9-35.0%)).
“Overall, the pooled period prevalence of loneliness among older adults was 28.6% (95% CI: 22.9-35.0%) and 31.2% for social isolation (95% CI: 20.2-44.9%).”
COVID-19 pandemic is associated with metabolic syndrome in humans (Korean adults; fully adjusted comparison with the pre-pandemic period) (OR 1.077, 95% CI 0.999-1.161).
“the fully adjusted odds of MetS were not significantly higher during the pandemic (OR, 1.077; 95% CI, 0.999-1.161)”
HumansKorean adults; fully adjusted comparison with the pre-pandemic period2020-2021
COVID-19 pandemic is associated with metabolic syndrome in humans (post-COVID-19 vs 2017) (48.1% vs 48.2% (IDF), 45.0% vs 44.1% (ATP III), p > 0.05).
“There was no change in the crude prevalence of MetS among the total population between 2017 (48.2% and 44.1%) and 2024 (48.1% and 45.0%) by IDF and ATP III criteria, respectively (p > 0.05).”
COVID-19 pandemic is associated with physical activity in humans.
“Covid-19 pandemic independently affected type of residence, smoking habits, BMI and WHR status, risk of depression, quality of life, cognitive status, physical activity levels, and MD adherence.”
COVID-19 pandemic is associated with body weight in humans (+1.15 ± 6.10 kg).
“The trend of weight change was found to increase by an average of 1.15 ± 6.10 kg (female +0.72 ± 5.51, male +2.16 ± 7.22 kg) for the first year of the COVID-19 pandemic.”
COVID-19 pandemic is associated with body weight in humans during the COVID-19 pandemic (Weight gain reported in 19.5–50.0%; weight loss in 13.8–50.7%).
“The COVID-19 pandemic has been associated with increased weight gain, largely attributable to lifestyle changes, including dietary habits and reduced physical activity.”
COVID-19 pandemic is linked with a higher risk of obesity in humans (COVID period vs pre-COVID period) (1.42 times).
“The odds of having obesity, abnormal triglycerides, and depression among individuals in the COVID period were 1.42 times, 1.38 times, and 2.65 times more than the odds in the pre-COVID period”
COVID-19 pandemic is linked with a higher risk of hip fracture in humans during the COVID-19 pandemic (2020-2024) compared to pre-pandemic (2015-2019) (78 vs 134 cases, Wilcoxon p = 0.0461).
“Statistical analysis showed a significant increase in HF incidence during the pandemic (Wilcoxon p = 0.0461; Kruskal-Wallis p = 0.0495) in this rural and aged community.”
Humansduring the COVID-19 pandemic (2020-2024) compared to pre-pandemic (2015-2019)
COVID-19 pandemic is associated with brain age gap in humans (Pandemic group compared with participants whose two scans preceded the pandemic) (5.5-month higher deviation at the second time point compared with controls).
“The Pandemic group shows on average 5.5-month higher deviation of brain age gap at the second time point compared with controls.”
HumansPandemic group compared with participants whose two scans preceded the pandemicbrainn = 996
COVID-19 pandemic is associated with brain age gap in humans (Pandemic group compared with participants whose two MRI scans preceded the pandemic) (11-month higher deviation of brain age gap at the second time point).
“The “Pandemic” group showed on average 11-month higher deviation of brain age gap at the second time point compared with controls.”
HumansPandemic group compared with participants whose two MRI scans preceded the pandemicbrainn = 1,336
COVID-19 pandemic is associated with life expectancy in humans (Hong Kong; compared with the pre-pandemic trend) (2.22 years lower (95% CI: 2.08, 2.36); life expectancy 80.4 years).
“corresponded to reductions by 2.22 (95% CI: 2.08, 2.36) years in males and 2.30 (95% CI: 2.17, 2.43) years in females.”
HumansHong Kong; compared with the pre-pandemic trend2022males
The COVID-19 pandemic is linked with higher mortality and lower physical activity and social participation in human studies, with independent labs reporting the same changes. Some studies report no clear mortality link, while a human study links the pandemic with higher physical activity. Some papers declare company ties.
Human studies associate the COVID-19 pandemic with higher mortality, a result repeated by independent labs, and older brain-age estimates. Independent labs also report reduced physical activity and social participation, although other studies report unchanged mortality or increased physical activity. Some authors have company affiliations, and some papers declare company ties.
Summary rewritten as its findings changed.
As it read before
Human studies associate the COVID-19 pandemic with increased mortality, impaired daily functioning, and loneliness, with independent labs reporting the same patterns. Studies also report higher brain-age measures, while physical activity results point both ways, mostly toward decreases. One of 94 papers declares company ties.
Summary rewritten as its findings changed.
As it read before
One human study reports decreased Pap smear screening but increased HPV vaccination rates during the COVID-19 pandemic in 2020. A human preprint associates the pandemic with excess mortality over 2020–2025.
Across groups defined by sex, race and ethnicity, education, income and insurance, predicted probabilities of cardiovascular disease ranged from 0.04% to 15.91%.Across groups defined by sex, race and ethnicity, education, income and insurance, predicted probabilities of cardiovascular disease ranged from 0.04% to 15.91%.
Death rates were 5.68% in 2023 and 5.62% in 2024, versus 5.15% in 2018 and 5.22% in 2019, but age- and sex-adjusted trends mostly declined.Death rates were 5.68% in 2023 and 5.62% in 2024, versus 5.15% in 2018 and 5.22% in 2019, but age- and sex-adjusted trends mostly declined.
Annual screening fell from 7.3% in January 2020 to 5.7%, recovered by March 2022 and reached 11% in June 2023.Annual screening fell from 7.3% in January 2020 to 5.7%, recovered by March 2022 and reached 11% in June 2023.
An aging-pace measure showed an estimated rise of 0.13 on the study’s statistical scale from prepandemic levels across children, adolescents and adults.An aging-pace measure showed an estimated rise of 0.13 on the study’s statistical scale from prepandemic levels across children, adolescents and adults.